# US 2002/0160990 A1 · Phytosterol and/or phytostanol derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0160990 A1
- Document ID: US20020160990A1
- Status: Published application
- Kind: A1
- Application number: 09/448,356
- Filed: 1999-11-23
- Published: 2002-10-31
- Earliest claimed: 1998-11-26
- Inventors: DAVID CARL BURDICK; GERARD MOINE; DANIEL RAEDERSTORFF; PETER WEBER
- Web page: https://patentgrep.com/patent/US20020160990A1

## CPC

- A61K 31/56: Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A23D 9/013: Other fatty acid esters, e.g. phosphatides
- A23L 33/11: Plant sterols or derivatives thereof, e.g. phytosterols
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/06: Antihyperlipidemics
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23D: EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS (preservation thereof A23B20/00; production, refinement or preservation of animal or vegetable fats or oils C11B, C11C)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a phytosterol and/or a phytostanol ester compound produced from the reaction of a phytosterol and/or a phytostanol with a polyunsaturated fatty acid (PUFA), wherein the polyunsaturated fatty acid has from 18 to 22 carbon atoms and at least three carbon-carbon double bonds. Processes for producing and compositions and a process for using such compositions are also provided.

## Claims

### Claim 1

A phytosterol and/or a phytostanol ester compound produced from a reaction of a phytosterol and/or a phytostanol with a polyunsaturated fatty acid, wherein the polyunsaturated fatty acid has from 18 to 22 carbon atoms and at least three carbon-carbon double bonds.

### Claim 2 (depends on 1)

A compound according to claim 1 wherein the phytosterol is selected from the group consisting of beta-sitosterol, stigmasterol, campesterol, and mixtures thereof.

### Claim 3 (depends on 2)

A compound according to claim 2 wherein the phytosterol is selected from the group consisting of beta-sitosterol, stigmasterol, and mixtures thereof.

### Claim 4 (depends on 3)

A compound according to claim 3 wherein the phytosterol is beta-sitosterol.

### Claim 5 (depends on 1)

A compound according to claim 1 wherein the phytostanol is selected from the group consisting of campestanol, beta-sitostanol, and mixtures thereof.

### Claim 6 (depends on 5)

A compound according to claim 5 wherein the phytostanol is beta-sitostanol.

### Claim 7 (depends on 1)

A compound according to claim 1 wherein the polyunsaturated fatty acid is eicosapentaenoic acid or docosahexaenoic acid.

### Claim 8 (depends on 1)

A composition comprising a compound according to claim 1 in admixture with another ester of a phytosterol and/or a phytostanol optionally also in admixture with a free phytosterol, a free phytostanol, and/or PUFA glycerides or esters, said another ester of a phytosterol and/or a phytostanol being the product of the esterification reaction between a phytosterol and/or a phytostanol and a fatty acid having less than 18 or more than 22 carbon atoms and at least three carbon-carbon double bonds and/or a fatty acid having from 18 to 22 carbon atoms and less than three carbon-carbon double bonds.

### Claim 9

A composition for lowering serum cholesterol and triglyceride levels in a mammal comprising a pharmaceutically acceptable carrier in combination with an effective amount of phytosterol and/or a phytostanol ester compound produced from a reaction of a phytosterol and/or a phytostanol with a polyunsaturated fatty acid having from 18 to 22 carbon atoms and at least three carbon-carbon double bonds.

### Claim 10 (depends on 9)

A composition according to claim 9 wherein the pharmaceutically acceptable carrier and phytosterol and/or phytostanol ester compound are formed into a unit dosage form.

### Claim 11 (depends on 10)

A composition according to claim 10 wherein the unit dosage form is selected from the group consisting of capsules, powders, liquids, gels, and tablets.

### Claim 12 (depends on 10)

A composition according to claim 10 wherein the composition is a dietary supplement or a food ingredient.

### Claim 13 (depends on 10)

A composition according to claim 10 wherein the mammal is a human.

### Claim 14 (depends on 1)

A process for lowering serum cholesterol and triglyceride levels in a mammal comprising administering to the mammal an effective amount of the compound of claim 1 in combination with a pharmaceutically acceptable carrier.

### Claim 15

A process for preparing a phytosterol and/or a phytostanol ester compound comprising esterifying a free phytosterol, a phytostanol or a mixture thereof with a n-3 polyunsaturated fatty acid having from 18 to 22 carbon atoms and at least three carbon-carbon double bonds.

### Claim 16

A process for preparing a phytosterol and/or a phytostanol ester compound comprising:
(a) mixing, in the absence of a solvent, a free phytosterol and/or a phytostanol, an ester of a n-3 polyunsaturated fatty acid (PUFA), and an interesterification catalyst to form a reaction mixture; and
(b) heating the reaction mixture to obtain interesterification of the phytosterol and/or the phytostanol with the ester of the n-3 PUFA.

### Claim 17 (depends on 16)

A process according to claim 16 wherein the ester is a simple C1-C4-ester or a triglyceride.

### Claim 18 (depends on 16)

A process according to claim 16 wherein the interesterification catalyst is a sodium alkoxide of a C1-C4-alcohol.

### Claim 19 (depends on 16)

A process according to claim 16 wherein the reaction mixture is heated from about 80° C. to about 140° C. at a pressure of about 133 Pa to about 6650 Pa.

### Claim 20 (depends on 16)

A process according to claim 16 wherein interestification is carried out with a stoichiometric amount to an excess of the ester of the n-3 PUFA.
